GLP-1 Drugs for Women Over 40

Join host Julia Cartwright as she unpacks the science behind GLP-1 drugs and why they're transforming weight management for women over 40 navigating perimenopause and menopause. From metabolic changes to muscle preservation and unexpected benefits, Julia explores research-backed truth about these medications and your changing body.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Julia Cartwright explores how GLP-1 drugs like semaglutide may offer women over 40 more than weight loss—potentially reducing heart disease risk, improving cholesterol, helping PCOS symptoms, and showing early signals of lowered cancer risk. She examines the science behind cardiovascular protection during menopause and discusses what happens when treatment stops.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Julia Cartwright examines GLP-1 medications for women over forty, covering muscle and bone density concerns, gallbladder risks, and resistance training essentials. She explores a Mayo Clinic study showing hormone replacement therapy combined with tirzepatide produced 35% greater weight loss in postmenopausal women, revealing how menopause management and metabolic health intersect in powerful ways.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Julia Cartwright explores why GLP-1 drugs like semaglutide and tirzepatide achieve 20-23% weight loss in menopausal women despite hormonal chaos. Drawing on SURMOUNT trial data involving over 2,500 women, she examines how estrogen decline drives visceral fat and insulin resistance—and why these medications work across all reproductive stages, challenging assumptions about midlife metabolism.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.